| Main topic |
Clinics |
| Subtopic |
Challenging clinical scenario: Why or why not particle therapy |
| Subtopic |
Clinical implementation of adaptive particle therapy |
| Subtopic |
Combined particle therapy with novel systemic therapy: efficacy and toxicities |
| Subtopic |
Comparative effectiveness and cost-effectives analysis |
| Subtopic |
Complementary therapy in particle therapy (rehabilitation) |
| Subtopic |
General clinical results and patient reported outcome |
| Subtopic |
LET and variable RBE based particle therapy |
| Subtopic |
Long-term complications and image changes after particle therapy |
| Subtopic |
Novel treatment strategies using particle therapy |
| Subtopic |
Particle therapy -based stereotactic radiotherapy and hypo-fractionated radiotherapy |
| Subtopic |
Particle therapy-based re-irradiation |
|
|
| Main topic |
Physics |
| Subtopic |
Beam delivery and nozzle design |
| Subtopic |
Dosimetry |
| Subtopic |
Imaging |
| Subtopic |
Motion management and adaptive therapy |
| Subtopic |
New approaches (e.g. ultra-high dose rate, spatially fractionated therapy) |
| Subtopic |
Outcome modelling |
| Subtopic |
Quality assurance |
| Subtopic |
Treatment planning – algorithms and methods |
| Subtopic |
Treatment planning – applications |
|
|
| Main topic |
Biology |
| Subtopic |
Biological advantages of CPRT vs XRT |
| Subtopic |
Biomarkers of CPRT response |
| Subtopic |
BNCT |
| Subtopic |
FLASH and mini-beam biology |
| Subtopic |
Immune therapy with CPRT |
| Subtopic |
Integrating biology in treatment planning: RBE and beyond |
| Subtopic |
Mathematical modeling & simulations of charged particle radiotherapy |
| Subtopic |
Targeted agents with CPRT |
